BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gauchy AC, Hentzien M, Wynckel A, de Marcellus V, Rodier C, Delmer A, Quinquenel A. Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia. Clin Case Rep 2020;8:2641-4. [PMID: 33363796 DOI: 10.1002/ccr3.3250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Pacillo L, Giardino G, Amodio D, Giancotta C, Rivalta B, Rotulo GA, Manno EC, Cifaldi C, Palumbo G, Pignata C, Palma P, Rossi P, Finocchi A, Cancrini C. Targeted treatment of autoimmune cytopenias in primary immunodeficiencies. Front Immunol 2022;13:911385. [DOI: 10.3389/fimmu.2022.911385] [Reference Citation Analysis]
2 Jackson EM, Harper S, Webb GJ, Thomas W. Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab. BMJ Case Rep 2022;15:e250774. [DOI: 10.1136/bcr-2022-250774] [Reference Citation Analysis]
3 Multiple drugs. Reactions Weekly 2021;1870:230-230. [DOI: 10.1007/s40278-021-01440-7] [Reference Citation Analysis]
4 Barcellini W, Giannotta JA, Fattizzo B. Autoimmune Complications in Hematologic Neoplasms. Cancers (Basel) 2021;13:1532. [PMID: 33810369 DOI: 10.3390/cancers13071532] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]